SCHEMBL5267693

SCHEMBL5267693

COC(=O)c1cc(-c2cnc(C)cn2)n(-c2ccc(OC)nn2)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
TSHR P16473 2/20 0.40
NPC1 O15118 1/20 0.34
RECQL P46063 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C19 P33261 1/20 0.34
PTGS2 P35354 1/20 0.34
ALOX5 P09917 1/20 0.34
NPSR1 Q6W5P4 1/20 0.33
KDM4E B2RXH2 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
KMT2A Q03164 2/20 0.33
PKM P14618 1/20 0.32
MEN1 O00255 1/20 0.32
NNMT P40261 1/20 0.32
JAK1 P23458 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5266552 0.90 ALDH1A1 (0.43) ALDH1A1TSHRNPC1RECQLRAB9A
SCHEMBL5269426 0.88 SMN1; SMN2 (0.38) ALDH1A1TSHRRAB9ASMN1; SMN2CYP1A2
SCHEMBL5269545 0.88 ALDH1A1 (0.37) ALDH1A1TSHRSMN1; SMN2PTGS2ALOX5
SCHEMBL5270243 0.85 SMN1; SMN2 (0.40) ALDH1A1TSHRNPC1RECQLRAB9A
SCHEMBL5528164 0.85 ALDH1A1 (0.39) ALDH1A1TSHRNPC1RECQLRAB9A
SCHEMBL5522342 0.83 JMJD6 (0.39) ALDH1A1TSHRSMN1; SMN2PTGS2ALOX5
SCHEMBL5266917 0.83 PTGS2 (0.43) NPC1RAB9ASMN1; SMN2PTGS2NPSR1
SCHEMBL5268935 0.82 EGLN2 (0.39) ALDH1A1TSHRKDM4E
SCHEMBL5271855 0.81 GABRA1 (0.42) ALDH1A1TSHRALOX5HPGD
SCHEMBL5266650 0.81 GSK3B (0.35) ALDH1A1TSHRALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070254881-A1 Pyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-11-01 US disclosed
US-20070219210-A1 Amidopyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-09-20 US disclosed
EP-1785418-A1 PYRAZOLE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-05-16 EP disclosed
EP-1698626-A1 AMIDOPYRAZOLE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-09-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254881-A1 Pyrazole Derivative PTGER1, PTGS1, PTGER2 ALDH1A1 111/4885TSHR 4178/4885NPC1 4323/4885
US-20070219210-A1 Amidopyrazole Derivative PTGER1, PTGS1, PTGER2 ALDH1A1 171/4885TSHR 3156/4885NPC1 4459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.